Heart Vessels and Transplantation最新文献

{"title":"Superior vena cava syndrome and pacemaker leads. Explant by mechanical dissection system of extraction and percutaneous recanalization with stents for new device implantation","authors":"E. G. Villegas, Joan Novo Torres, E. Domingo, Maria Dolores Ponce Dorrego, José Ignacio Del Rio, U. R. Valdiris, Jose Carlos Romero Carmona, Isabel Franco Fernandez, R. Peinado","doi":"10.24969/hvt.2023.372","DOIUrl":"https://doi.org/10.24969/hvt.2023.372","url":null,"abstract":"Objective: Superior venous system stenosis (superior vena cava (SVC) - right subclavian vein - innominate vein - left subclavian vein) is a clinical situation that frequently appears in patients with long-term implanted cardiac stimulation devices, due to venous system thrombosis and in those with congenital heart disease who need corrective surgery, due to chronic complications inherent to surgical techniques. In clinical practice, venous system stenosis may manifest as a SVC syndrome. In many cases, we are not able to correct stenosis or obstructions, since it is impossible to cross them. In this article, we describe the surgical technique that we have implemented in our hospital to solve this challenge, especially in those patients with pacing/defibrillation devices who present with this pathology. Our objective was to perform an extraction of the pacemaker and defibrillation electrodes, to allow the passage of a support wire to achieve the implantation of the endovascular stent(s) to correct the SVC syndrome. Methods: We present a retrospective series of six consecutive patients with SVC syndrome studied in a single center from 2012 to 2021.Three of them presented with thrombosis related to pacing or defibrillation electrodes and the other three presented with complications derived from Mustard or Senning techniques in patients with pacemakers and D-transposition of the great arteries. Results: In all cases, a complete re-vascularization of the SVC system was achieved using a stent, and new leads could have been implanted through it. Combined treatment of lead extraction and endovascular stent implantation corrected the syndrome in all cases. Conclusions: Angioplasty and stenting of the central venous system is a standardized technique with validated results, in acute, for the recanalization of chronic occlusions secondary to transvenous devices.","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88466250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comments on new 2022 European Society of Cardiology guidelines on cardioncology","authors":"Zhenisgul Tlegenova, Saule K Balmagambetova","doi":"10.24969/hvt.2023.370","DOIUrl":"https://doi.org/10.24969/hvt.2023.370","url":null,"abstract":"Abbreviations ACE-I angiotensin-Converting Enzyme Inhibitor ACS –acute coronary syndrome ARB angiotensin Receptor Blocker CScancer survivors cTn – cardiac troponin CTRCD – cancer therapy-related cardiac dysfunction CTR-CVT – cancer therapy-related cardiovascular toxicity CVD – cardiovascular disease ECG electrocardiogram ECHO echocardiography GLS – global longitudinal strain HF – heart failure HFA-ICOS – heart Failure Association International Cardio-Oncology Society ICIs immune checkpoint inhibitors LVEF – left ventricular ejection fraction MDT – multidisciplinary team QTcFcorrected QT interval using Fridericia correction RF risk factor RT Radiotherapy","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82546331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous balloon mitral valvuloplasty in rheumatic mitral stenosis: the earlier the merrier?","authors":"G. Biondi-Zoccai, Theodora Metsovitis, Beatrice Fresch, M. Bernardi, F. Perone","doi":"10.24969/hvt.2023.369","DOIUrl":"https://doi.org/10.24969/hvt.2023.369","url":null,"abstract":"Catholic University of the Sacred Heart, Rome, Italy Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome,Italy Cardiac Rehabilitation Unit, Rehabilitation Clinic \"Villa delle Magnolie\", Castel Morrone, Caserta, Italy Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy Mediterranea Cardiocentro, Napoli, Italy","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"94 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87675840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acute Coronary Syndrome in Older Adults: an Update from the 2022 Scientific Statement by the American Heart Association","authors":"Stefano Cacciatore, A. M. Martone, F. Landi, M. Tosato","doi":"10.24969/hvt.2023.367","DOIUrl":"https://doi.org/10.24969/hvt.2023.367","url":null,"abstract":"On December 2022, the American Heart Association (AHA) released a new scientific statement on management of acute coronary syndrome (ACS) in older adults. (1) Here we summarize and comment on some of the key points from the paper.","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80575831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Benefits of early mobilization in patients with deep venous thrombosis: a scope review","authors":"Augusto Robson de Alencar Martins, L. R. Rodrigues Júnior, Juliana Rega de Oliveira","doi":"10.24969/hvt.2023.366","DOIUrl":"https://doi.org/10.24969/hvt.2023.366","url":null,"abstract":"Objective: Deep venous thrombosis (DVT) is a blood flow obstruction caused by the formation of a thrombus in deep system veins, with higher prevalence in lower limbs. Bed restriction has been indicated in patients with DVT in order to avoid pulmonary embolism caused by displacement of the thrombus. However, immobility has recently been considered a risk factor for DVT, not only due to blood flow stasis, but also by secondary complications as muscle atrophy and weakness. Objective was to review the possible benefits of early mobilization in patients with DVT in the intensive care unit.\u0000\u0000Methods: A scope review of literature was conducted. The following keywords were used: deep venous thrombosis, early mobilization and physical therapy. The search was made on Pubmed and Scielo databases. Results: 20 studies were found and 7 articles were included in the review using the exclusion criteria.\u0000\u0000Conclusion: Early mobilization association with anticoagulation and compression was described as essential in the treatment of DVT, reducing deleterious effects of immobility, pain, edema, and promoting quality of life improvement.\u0000","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88808867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictive significance and diagnostic accuracy of plasma fibrinogen levels for coronary stenting outcomes","authors":"T. Bansal, Anand N. Shukla, Rujuta Parikh, Gaurav Singh, A. Mishra, L. Singh, K. Patel, I. Patel, Utsav A. Patel","doi":"10.24969/hvt.2022.365","DOIUrl":"https://doi.org/10.24969/hvt.2022.365","url":null,"abstract":"Objective: The advancement in percutaneous transluminal coronary angioplasty (PTCA) has led to it becoming the predominant mode of revascularization. Post PTCA adverse events in the form of stent thrombosis, recurrent ischemia, unplanned revascularization, recurrent hospitalization etc. result in morbidity as well as mortality. Biomarkers predicting such outcomes can be useful in initiating more aggressive medical therapy and greater modification of risk factors. This study was undertaken to study the predictive significance of periprocedural plasma fibrinogen levels for coronary stenting outcomes.\u0000\u0000Methods: 80 patients diagnosed as either chronic stable angina (CSA), unstable angina (UA), Non ST Elevation Myocardial Infarction (NSTEMI) or late presentation ST Elevation Myocardial Infarction (STEMI) undergoing planned PTCA were included in study. Patients were evaluated for clinical history, electrocardiogram (ECG), two dimensional echocardiography (2D-echo) and cardiac biomarkers (Creatinine Phorphokinase-MB isomer (CK-MB) and Troponin I). Serum fibrinogen level was measured 24 hours prior to PTCA along with routine pre-operative investigations; and also 24 hours after coronary stenting. Patients were followed for six months. Outcome measure was taken to be freedom from cardiac related adverse events, including rehospitalisation, unplanned repeat revascularization, definite stent thrombosis, transient ischemic attack, stroke and all-cause mortality.\u0000\u0000Results:  Fibrinogen level ≥393 mg/dL, 24 hours prior to percutaneous transluminal coronary angioplasty, was associated with higher major adverse cardiac and cerebrovascular events (MACCE) rates (60%) as compared to those with fibrinogen level <393 mg/dL (3.6%).  Fibrinogen level ≥427 mg/dL 24 hours after percutaneous transluminal coronary angioplasty, was associated with higher major adverse cardiac and cerebrovascular events rates (65%) as compared to those with fibrinogen level <427 mg/dL (6.7%).\u0000\u0000Conclusion: The current study demonstrates that higher baseline and post procedural fibrinogen, is an independent predictor of 6 months major adverse cardiac and cerebrovascular events after elective percutaneous coronary intervention.\u0000\u0000Key words:  Coronary stent outcomes, major adverse cardiac and cerebrovascular events, plasma fibrinogen, stent diameter\u0000","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"10 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72398826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between inflammation and cigarette smoking in cardiac remodeling after acute myocardial infarction","authors":"E. Kızıltunç, C. Şabanoğlu, M. A. Felekoğlu, Nilnur Eyerci, Orhan Karayiğit, O. Ates","doi":"10.24969/hvt.2022.361","DOIUrl":"https://doi.org/10.24969/hvt.2022.361","url":null,"abstract":"Objective: In this study, we aimed to investigate the relationship between smoking and adverse cardiac remodeling after ST-elevation MI (STEMI), and the association between smoking and inflammatory markers, including cytokine levels. Methods: Forty-three patients admitted to the emergency department between June 2015 and June 2020 who were diagnosed with STEMI for the first time and underwent successful primary percutaneous coronary intervention were included in the study. Inflammatory markers (interferon (IFN)- α, - γ, - β, interleukin (IL)-6R- α, and soluble tumor necrosis factor receptor (sTNFR)-1,-2) were measured on the first day and two weeks post-MI. Left ventricular volume and functions were evaluated using cardiac magnetic resonance imaging at two weeks and six months post-STEMI. Adverse remodeling (AR) was defined as an increase in left ventricular (LV) end-diastolic volume >12%. Results: The AR ratio (65% vs. 30.4%; p= 0.024) and the levels of each inflammatory marker on the first-day post-STEMI were higher in the smokers' group than in the non-smokers' group. Smoking (OR= 4.46; p= 0.032) and IFN-β (OR= 1.07; p=0.023) levels on the first-day post-MI were independent predictors of AR. Also, smoking ( β( SE)= 8.96(2.74); p= 0.002), increased neutrophil levels (β±SE= 1.72 (0.66); p= 0.013) and inc reased LDL levels (β( SE) = 0.07(0.03); p=0.031) were independent predictors of elevated IFN-β levels. Conclusion: Baseline inflammatory marker levels and incidence of AR post-STEMI were higher in smokers. Smoking can contribute to the development of AR by increasing the severity of inflammation at the onset of acute STEMI.","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78693515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: which impact to lung cancer resection?","authors":"F. Tacconi","doi":"10.24969/hvt.2022.359","DOIUrl":"https://doi.org/10.24969/hvt.2022.359","url":null,"abstract":"In August 2022, the European Society of Cardiology, with endorsement of the European Society of Anesthesiology and Intensive Care, issued the updated guidelines regarding overall management of patients scheduled for non-cardiac surgery (1). The document contains a massive amount of new concepts, updates and revisions, and first of all the surgical community should express gratitude to all the colleagues who contributed to this challenging task. The ESC guidelines embrace several points, each one representing a daily challenge in decision-making processes, especially when dealing with patients with cardiovascular risk factors. The topics touched deal with preoperative assessment of cardiac function, management of blood thinners, risk reduction strategies, and many others points. While issued recommendations are not meant to be oriented to a specific surgical field, their connection to the main key points of lung cancer surgery is very strict. Indeed, compared to other surgical subspecialties, lung resections carry myriads of cardiac and vascular implications. First of all, lung cancer patients are very often current or former smokers, which implies a higher risk of coronary artery disease and other cardiovascular comorbidities. Furthermore, thoracic surgery exposes patients to postoperative cardiovascular complications also due to its specific pathophysiologic changes and anatomical relationships. Possible specific mechanisms of cardiac involvement during and after lung surgery are (but not limited to): increased right ventricular dysfunction secondary to lung tissue removal (2, 3), induction of arrhythmias due to vagus nerve injury (4, 5), induction of postoperative hypoxia due to chest pain and phlegm retention, and reduced blood venous return in case of massive mediastinal shift. Several recommendations from updated ESC guidelines intimately deal with all these points and deserve a focused comment. For example, in the new recommendations section, it is mentioned that minimally-invasive accesses can be adopted as a risk-reduction strategy. In lung cancer surgery, this means that video-assisted procedures (VATS) in lieu of open thoracotomy should be strongly considered as the best option for performing lung resection, especially to patients with high cardiovascular risk. However, the class of recommendation is regarded as IIa, meaning that – even though VATS should be considered as the best choice the indication is still not compulsory. The recommendation seems reasonable, by virtue on the current knowledge on this topic. Certainly, in the last two decades, VATS has become the standard method to perform lung resection in an increasing number of surgical centers all around the world. The rationale of this revolution is that patients are assumed to benefit from the reduced surgical traumatism and reduced postoperative chest pain. Both these factors should lead to a faster recovery and less inflammatory perturbation, ultimately translating into less","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"141 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79606862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of the COVID-19 pandemic on the use of myocardial perfusion imaging for the assessment of coronary artery disease: a Brazilian experience","authors":"A. De Lorenzo, Mariana Canario, V. Souza, R. Lima","doi":"10.24969/hvt.2022.358","DOIUrl":"https://doi.org/10.24969/hvt.2022.358","url":null,"abstract":"This study sought to evaluate the influence of the COVID-19 pandemic on the use of MPI for the assessment of CAD in a Nuclear Cardiology laboratory in Rio de Janeiro, Brazil. The frequency of abnormal MPI, as well as the proportion of tests with ischemia or fibrosis were not significantly different among the groups.  Abnormal MPI tests pre-lockdown was 204 and the number during lockdown - 8, the percentage of “missing” abnormal tests was of 81%. The logistic regression analysis showed that age (OR=11.4, p<0.001), the presence of at least 1 cardiac risk factor (OR=4.4, p=0.036), and known CAD (OR=5.27, p=0.02) were independent. Predictors of the performance of MPI during the lockdown period, with an inverse association with age (β= -0.053).\u0000\u0000This study reinforces the perception that in current days, and possibly for a long time, there should be continued surveillance over CAD incidence and manifestations, due to potentially missed diagnoses secondary to the COVID-19 pandemic.\u0000","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83169892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Left atrial appendage occlusion EP course","authors":"L. Arabia","doi":"10.24969/hvt.2022.354","DOIUrl":"https://doi.org/10.24969/hvt.2022.354","url":null,"abstract":"","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"4 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83437621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}